pillbase.ru

Rilonacept Regeneron (previously Arcalyst)

Active substance: rilonacept

rilonacept

Centralised EU authorisationWithdrawn

Marketing holder: Regeneron UK Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • Arcalyst
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · RILONACEPT 160 mg/2mL
    73604-914
    Kiniksa Pharmaceuticals (UK), Ltd.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-d116-7e82-a3bf-b68dd1232dbd;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/001047
Registration status
Withdrawn
ATC code
L04AC08
Sources
  • product · EMA · EMEA/H/C/001047 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/001047 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/001047 · Verified 2026-10-09